The investigational therapy telitacicept leads to significant and clinically meaningful reductions in disease activity and patient-reported symptoms among adults with…
Articles by Lindsey Shapiro, PhD
Novartis’ investigational antibody therapy ianalumab (VAY736) safely and effectively eases disease activity in adults with Sjögren’s disease, topline…
A naturally occurring molecule that has the ability to regulate gene activity may represent a promising therapeutic target for…
A mutation in the TNIP1 gene resulted in a chronic autoimmune disease for two people, one of whom had symptoms…
Kiniksa Pharmaceuticals has launched a Phase 2b clinical trial to test its injectable therapy abiprubart against a placebo in…
Dry cough and shortness of breath were found to be significant predictors of interstitial lung disease (ILD) with scarring in…
Osteoarthritis, rather than inflammatory arthritis, was the more common cause of joint pain among primary Sjögren’s syndrome patients in…
A gene called PSMC6 may be involved in driving inflammation and immune cell infiltration into the glands affected by primary Sjögren’s…
Investigational therapy dazodalibep significantly eased symptom burden in people with Sjögren’s syndrome who have moderate-to-severe symptoms, but minimal systemic…
Age, disease duration, and blood levels of inflammatory markers Krebs von den Lungen-6 (KL-6) and TNF-alpha are the most discriminating…